| Name: | Fulvestrant EP Impurity B |
| Catalogue No. | VL234004 |
| CAS No. | 98008-06-1 |
| Molecular Formula | C32H47F5O4S |
| Molecular Weight | 622.77 |
| Status | In-stock |
| IUPAC Name | 7α-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfonyl]nonyl]estra-1,3,5(10)-triene-3,17β-diol |
| Synonyms | Fulvestrant Sulfone |
| Appearance | White solid |
| Description | Fulvestrant EP Impurity B (CAS No. 98008-06-1) or (7α,17β)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfonyl]nonyl]estra-1,3,5(10)-triene-3,17-diol is an impurity of Fulvestrant. Fulvestrant is a drug treatment of hormone receptor (HR)-positive metastatic breast cancer in post-menopausal women with disease progression following anti-estrogen therapy. |
| References | “Sci-Hub | Combination Anastrozole and Fulvestrant in Metastatic Breast Cancer | 10.1056/Nejmoa1201622.” Hkvisa.net, 2012, sci-hub.hkvisa.net/10.1056/nejmoa1201622. |
![7β-Acetyloxy-7α-[9-(dimethyl(tert-butylsilyloxy)nonyl]estr-4-en-3-one](/public/site/files/site_images/thumb_7beta-acetyloxy-7alpha-9-dimethyl-tert-butylsilyloxy-nonyl-estr-4-en-3-one17932.png)
![Fulvestrant 9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonanol](/public/site/files/site_images/thumb_fulvestrant-944555pentafluoropentylthiononanol35935.PNG)
![Fulvestrant 9-[[9-[(4,4,5,5,5-Pentafluoropentyl)sulfenyl]nonyl]sulfenyl]nonyl Bromide](/public/site/files/site_images/thumb_fulvestrant-9944555pentafluoropentylsulfenylnonylsulfenylnonyl-bromide21235.PNG)
